Heliad invests in data-governance startup sci2sci for biopharma AI compliance layer

• Heliad invested in sci2sci to target regulated biopharma R&D data governance for AI, emphasizing traceability and auditability for regulators.
• VectorCat connects scattered data sources without migration, adds metadata, harmonizes formats, flags sensitive information to support compliant agent access.
• Integrity Cortex deterministically verifies LLM outputs against source data, aiming to reduce hallucinations and make datasets FAIR for reuse.
• sci2sci is running in production at a listed global biopharma company, alongside multiple customer pilots.
• Pricing scales with customer data volumes, positioning sci2sci as a potentially sticky layer in enterprise AI stacks as data grows 30% to 35% annually.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Heliad AG published the original content used to generate this news brief on September 08, 2026, and is solely responsible for the information contained therein.